MedTrace Logo

Project Health: Enhancing Effectiveness of a Dissonance-Based Obesity Prevention Program

NCT03710746 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 406

Last updated 2024-08-09

No results posted yet for this study

Summary

This project seeks to improve the effectiveness of a novel dissonance-based obesity prevention program that has reduced future BMI gain and overweight/obesity onset by (a) experimentally testing whether implementing it in single- versus mixed-sex groups, which should increase dissonance-induction that contributes to weight gain prevention effects, and (b) experimentally testing whether adding food response and attention training, which theoretically reduces valuation of and attention for high-calorie foods, increases weight gain prevention effects. This randomized trial would be the first to experimentally manipulate these two factors in an effort to produce superior weight gain prevention effects. A brief effective obesity prevention program that can be easily, inexpensively, and broadly implemented to late adolescents at risk for excess weight gain, as has been the case with another dissonance-based prevention program, could markedly reduce the prevalence of obesity and associated morbidity and mortality.

Conditions

  • Overweight and Obesity

Interventions

BEHAVIORAL

Project Health

A brief dissonance-based obesity prevention program delivered in six one-hour weekly sessions.

BEHAVIORAL

Response and Attention Training

Individualized, computerized response and attention training consisting of five separate tasks designed to increase inhibitory control to reduce overeating.

Sponsors & Collaborators

  • Drexel University

    collaborator OTHER

  • Oregon Research Institute

    lead OTHER

Principal Investigators

  • Eric M Stice, Ph.D. · Oregon Research Institute

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
FACTORIAL

Eligibility

Min Age
17 Years
Max Age
20 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-10-08
Primary Completion
2025-03-31
Completion
2025-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03710746 on ClinicalTrials.gov